| | | | | | | | | | |
|
Dockets Management
|
| Dockets Entered On
July 26, 2006
Table of Contents
|
|
|
|
|
|
|
| Docket #
|
| Title
|
|
|
|
|
| 1976N-0052N
|
| OTC Nasal Decongestants
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
| 2001N-0548
|
| Guidelines for Voluntary Nutrition Labeling of Raw Fruits
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
| 2004D-0198
|
| Guidance for Industry: Acceptable Full-Length Donor History Questionnaire and Accompanying Materials for Use in Screening Human Donors of Blood and Blood Components
|
|
|
| 2004N-0226
|
| Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 010
|
|
|
| 2005D-0021
|
| International Conference on Harmonisation; Draft Guidance on Q8 Pharmaceutical Development
|
|
|
| 2005N-0354
|
| Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| 2006D-0056
|
| Compliance Policy Guide Sec. 500.500 Guidance Levels for 3-MCPD (3-chloro-1, 2-propanediol) in Acid-Hydrolyzed Protein (Acid-HP) and Asian-Style Sauces
|
|
|
| 2006D-0246
|
| Manufactured Food Regulatory Program Standards
|
|
|
| 2006N-0038
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Irradiation in the Production, Processing, and Handling of Food
|
|
|
| 2006N-0133
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of Variations in Content and Format of the Brief Summary in Direct-to-Consumer (DTC) Print Adver
|
|
|
|
|
|
| 2006N-0284
|
| Medical Device Regulations; Addresses; Technical Amendment
|
|
|
| 2006O-0231
|
| Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredient
|
|
|
| 2006P-0151
|
| Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants
|
|
|
| 1976N-0052N
|
| OTC Nasal Decongestants
|
|
|
| EC 4
|
| Mrs. Brenda Wilson
|
| Vol #:
|
| 86
|
|
|
| 1998P-0151
|
| Introduction Of Downed Cattle Into The Food Supply
|
|
|
| EMC 4401
|
| A Jones
|
| Vol #:
|
| 320
|
|
|
| EMC 4402
|
| P Pan
|
| Vol #:
|
| 320
|
|
|
| EMC 4403
|
| D BUrket
|
| Vol #:
|
| 320
|
|
|
| EMC 4404
|
| unsigned
|
| Vol #:
|
| 320
|
|
|
| EMC 4405
|
| R Budin
|
| Vol #:
|
| 320
|
|
|
| EMC 4406
|
| unsigned
|
| Vol #:
|
| 320
|
|
|
| EMC 4407
|
| N Desmond
|
| Vol #:
|
| 320
|
|
|
| EMC 4408
|
| S Clay
|
| Vol #:
|
| 320
|
|
|
| EMC 4409
|
| D Godin
|
| Vol #:
|
| 320
|
|
|
| EMC 4410
|
| R Gonzalez
|
| Vol #:
|
| 320
|
|
|
| EMC 4411
|
| L Reynolds
|
| Vol #:
|
| 320
|
|
|
| EMC 4412
|
| J Argyle
|
| Vol #:
|
| 320
|
|
|
| EMC 4413
|
| D Tignanelli
|
| Vol #:
|
| 320
|
|
| | | | | | | | |
|
|
| EMC 4414
|
| P Morello
|
| Vol #:
|
| 320
|
|
|
| 1999P-1340
|
| Declared Eternity eau de Parfum Misbranded
|
|
|
| EMC 647
|
| A Miller
|
| Vol #:
|
| 24
|
|
|
| 2001N-0548
|
| Guidelines for Voluntary Nutrition Labeling of Raw Fruits
|
|
|
| NFR 1
|
| FDA
|
| Vol #:
|
| 5
|
|
|
| 2002P-0317
|
| Recall Aspartame as a Neurotoxic Drug
|
|
|
| EMC 675
|
| Mission Possible International
|
| Vol #:
|
| 10
|
|
|
| EMC 676
|
| B Martini
|
| Vol #:
|
| 10
|
|
|
| EMC 677
|
| Calorie Control Council
|
| Vol #:
|
| 10
|
|
|
| EMC 678
|
| Mission Possible International
|
| Vol #:
|
| 10
|
|
|
| 2003N-0076
|
| Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
|
|
|
| EMC 1326
|
| L Auricchio
|
| Vol #:
|
| 12
|
|
|
| EMC 1327
|
| B Beasey
|
| Vol #:
|
| 12
|
|
|
| 2004D-0198
|
| Guidance for Industry: Acceptable Full-Length Donor History Questionnaire and Accompanying Materials for Use in Screening Human Donors of Blood and Blood Components
|
|
| EMC 3
|
| C Kalczynski
|
| Vol #:
|
| 1
|
|
|
| 2004N-0226
|
| Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 010
|
|
|
| EC 12
|
| Mr. David Malone
|
| Vol #:
|
| 1
|
|
|
| EC 13
|
| Mr. Mark Leeuwenburgh
|
| Vol #:
|
| 1
|
|
|
| 2005D-0021
|
| International Conference on Harmonisation; Draft Guidance on Q8 Pharmaceutical Development
|
|
|
| EC 10
|
| Mr. Alan J. Potvin
|
| Vol #:
|
| 1
|
|
|
| 2005N-0354
|
| Consumer-Directed Promotion of Regulated Medical Products; Part 15 Public Hearing
|
|
|
| EMC 590
|
| CommonHealth
|
| Vol #:
|
| 12
|
|
|
| 2005P-0411
|
| Seeking FDA Actions to Counter Flagrant Violations of the Law by Pharmacies Compounding Bio-Identical Hormone Replacement Therapy Drugs
|
|
|
| C 17451
|
| P. Dick
|
| Vol #:
|
| 190
|
|
|
| C 17452
|
| J. Wilson
|
| Vol #:
|
| 190
|
|
|
| C 17453
|
| K. Steinke
|
| Vol #:
|
| 190
|
|
|
| C 17454
|
| B. Wells
|
| Vol #:
|
| 190
|
|
|
| C 17455
|
| P. Perruc
|
| Vol #:
|
| 190
|
|
|
| C 17456
|
| J. Cresap
|
| Vol #:
|
| 190
|
|
|
| C 17457
|
| C. Van Vooren
|
| Vol #:
|
| 190
|
|
|
| C 17458
|
| S. McCachren
|
| Vol #:
|
| 190
|
|
| | | | | | | | |
|
|
| C 17940
|
| M. Schiller
|
| Vol #:
|
| 193
|
|
|
| C 17941
|
| P. Alder
|
| Vol #:
|
| 193
|
|
|
| EC 33256
|
| Ms. Robin Leventhal
|
| Vol #:
|
| 142
|
|
|
| 2006D-0056
|
| Compliance Policy Guide Sec. 500.500 Guidance Levels for 3-MCPD (3-chloro-1, 2-propanediol) in Acid-Hydrolyzed Protein (Acid-HP) and Asian-Style Sauces
|
|
|
| EC 1
|
| International Hydrolyzed Protein Council
|
| Vol #:
|
| 1
|
|
|
| 2006D-0246
|
| Manufactured Food Regulatory Program Standards
|
|
|
| EMC 1
|
| B Sachau
|
| Vol #:
|
| 1
|
|
|
| EMC 2
|
| B Sachau
|
| Vol #:
|
| 1
|
|
|
| 2006N-0038
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Irradiation in the Production, Processing, and Handling of Food
|
|
|
| NAL 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| SS 1
|
| Background Material
|
| Vol #:
|
| 1
|
|
|
| 2006N-0133
|
| Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Evaluation of Variations in Content and Format of the Brief Summary in Direct-to- Consumer (DTC) Print Adver
|
|
|
|
|
|
| EMC 4
|
| Merck & Co. Inc
|
| Vol #:
|
| 1
|
|
|
| 2006N-0284
|
| Medical Device Regulations; Addresses; Technical Amendment
|
|
|
| NFR 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006O-0231
|
| Over-the-Counter Drug Products; Safety and Efficacy Review; Additional Sunscreen Ingredient
|
|
|
| BKG 1
|
| Background
|
| Vol #:
|
| 1
|
|
|
| NRD 1
|
| FDA
|
| Vol #:
|
| 1
|
|
|
| 2006P-0151
|
| Stay the current approvable letter with conditions of any and all Premarket Applications for silicone gel-filled breast implants
|
|
|
| EC 668
|
| Ms. Connie Hunter
|
| Vol #:
|
| 3
|
|
|
| EC 669
|
| Dr. Mona Cardell
|
| Vol #:
|
| 3
|
|